Abstract
Ayahuasca is made from a mixture of Amazonian herbs and has been used for a few hundred years by the people of this region for traditional medicine. In addition, this plant has been shown to be a potential treatment for various neurological and psychiatric disorders.
EEG experiments have found specific brain regions that changed significantly due to ayahuasca. Here, we used an EEG dataset to investigate the ability to automatically detect changes in brain activity using machine learning and complex networks. Machine learning was applied at three different levels of data abstraction: (A) the raw EEG time series, (B) the correlation of the EEG time series, and (C) the complex network measures calculated from (B).
As a result, the machine learning method was able to automatically detect changes in brain activity, with case (B) showing the highest accuracy (92%), followed by (A) (88%) and (C) (83%), indicating that connectivity changes between brain regions are more important than connectivity changes within brain regions. The most activated areas were the frontal and temporal lobe, which is consistent with the literature.
In terms of brain connections, the correlation between F3 and PO4 was the most important. This connection may point to a cognitive process similar to face recognition in individuals during ayahuasca-mediated visual hallucinations.
Furthermore, closeness centrality and assortativity were the most important complex network measures. These two measures are also associated with diseases such as Alzheimer’s disease, indicating a possible therapeutic mechanism.
Overall, our results showed that machine learning methods were able to automatically detect changes in brain activity during ayahuasca consumption. The results also suggest that the application of machine learning and complex network measurements are useful methods to study the effects of ayahuasca on brain activity and medical use.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by CNPq (grant 309266/2019- 0) and FAPESP (grant 19/23293-0)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced are available online at https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/VVE6QC
https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/VVE6QC